• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE UNKNOWN; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE UNKNOWN; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number UNKNOWN
Device Problem Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problem No Information (3190)
Event Type  Injury  
Manufacturer Narrative
Catalog# is unknown but referred to as zenith alpha graft.
 
Event Description
Description of event according to initial reporter: a secondary intervention is scheduled on a case from a couple years ago.The case is schedule on (b)(6) 2020 and reason for the secondary intervention is for component separation of zenith alpha grafts, which is believed to be caused by the tortuosity of the anatomy.It was further reported, patient originally had a tevar on (b)(6) 2017 where a zta-p-40-167-w as implanted proximally, followed by zta-p-46-125-w hybrid debranching/tevar on (b)(6) 2018 zta-36-32-161-w placed distally, then telescoped zta-pt-42-38-225-w, followed by zta-pt-42-38-173 into the zta-p-40-167-w.Secondary intervention due to separation of the zta-36-32-161-w from the zta-pt-42-38-225 placed zta-pt-42-38-225-w followed distally with a zta-pt-38-34-217-w.Outcome reported not symptomatic from prior secondary intervention.Aneurysm growth present due to separation.No endoleak documented between 6 mo.Visits.Imaging prior and subsequent to the secondary intervention? 6 mo.Ct¿s.Working on gathering this info.Aneurysm reportedly measures 6.3 c.Patient outcome subsequent to the secondary intervention reportedly went well.Patient went home on day two doing well.30 day ct to be done in (b)(6) 2021.No planning or sizing information be provided, initial procedures in 2017 and 2018.Furthermore, tortuosity was present prior to first tevar in 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
MDR Report Key10994266
MDR Text Key222337239
Report Number3005580113-2020-00458
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 12/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/11/2020
Distributor Facility Aware Date11/17/2020
Event Location Hospital
Date Report to Manufacturer12/07/2020
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/11/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-